Finance

Lists
GYRE:NASDAQ
Gyre Therapeutics Inc
7,11 USD
+1,57%
(+0,11) 1D
7,11 USD
0,00% (0,00)
After hours
Closed: 2-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
7,09 USD
High
7,35 USD
Low
7,08 USD
Mkt. cap
753,90 млн
Avg. vol.
150,78 миң
Volume
163,75 миң
52-wk high
9,42 USD
52-wk low
5,44 USD
EPS
-0,20 USD
Beta
2,18
Shares outstanding
106,03 млн
No. of employees
625
Open
7,09 USD
High
7,35 USD
Low
7,08 USD
Mkt. cap
753,90 млн
Avg. vol.
150,78 миң
Volume
163,75 миң
52-wk high
9,42 USD
52-wk low
5,44 USD
EPS
-0,20 USD
Beta
2,18
Shares outstanding
106,03 млн
No. of employees
625
News stories
From web sources and news partners
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
HeadquartersУинстон-Сейлем, Север Каролина, Америка Кошмо Штаттары
Sector-
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current 7,11 USD
20,00 USD (+181,29%)
Average
19,00 USD (+167,23%)
Lowest
18,00 USD (+153,16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
20,00 USD
+181,3%
08/10/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
18,00 USD
+153,2%
08/07/2026
Roger Song
Jefferies
Buy
Initiated
16,00 USD
+125%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
30,56 млн
37,20 млн
24,43 млн
29,10 млн
Cost of goods sold
1,63 млн
1,74 млн
1,23 млн
2,21 млн
Cost of revenue
1,63 млн
1,74 млн
1,23 млн
2,21 млн
Research and development expenses
2,36 млн
4,82 млн
11,48 млн
19,14 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,65 млн
30,52 млн
24,31 млн
21,62 млн
Operating expense
22,01 млн
35,33 млн
35,79 млн
40,76 млн
Total operating expenses
23,64 млн
37,08 млн
37,02 млн
42,97 млн
Operating income
6,93 млн
120,00 миң
-12,59 млн
-13,86 млн
Other non operating income
604,00 миң
-2,31 млн
244,00 миң
-811,00 миң
EBT including unusual items
7,63 млн
-66,00 миң
-18,03 млн
-14,43 млн
EBT excluding unusual items
7,63 млн
-864,00 миң
-11,65 млн
-13,93 млн
Income tax expense
1,69 млн
1,30 млн
549,00 миң
-164,00 миң
Effective tax rate
22,19%
-1 969,70%
-3,04%
1,14%
Other operating expenses
-
-
-
-
Net income
3,61 млн
-1,72 млн
-10,30 млн
-10,60 млн
Net profit margin
11,81%
-4,63%
-42,16%
-36,44%
Earnings per share
0,03
0,05
-
-
Interest and investment income
100,00 миң
1,35 млн
743,00 миң
740,00 миң
Interest expense
-
-
-
-
Net interest expenses
100,00 миң
1,35 млн
743,00 миң
740,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
7,58 млн
815,00 миң
-11,92 млн
-12,38 млн
Gain or loss from assets sale
1,00 миң
2,00 миң
16,00 миң
2,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору